PuraVerde
Farm to Pharma
Overview
Raised: $7,500
Total Commitments ($USD)
Dalmore Group
08/10/2022
Not Provided
$750
Equity - Common
Pre-Seed
RegA+
$1.50
$362,000,000
Rolling Commitments ($USD)
05/30/2023
$28
4
2018
Healthcare & Pharmaceuticals
Medtech
B2B2C
Low
High
Balance Sheet
|
Cash and Cash Equivalents |
$31,787 |
|
Accounts and Notes Receivable |
$171,388 |
|
Property, Plant and Equipment (PP&E) |
$3,598,264 |
| Total Assets |
$5,128,682 |
|
Accounts Payable & Accrued Liabilities |
$2,439,651 |
|
Long Term Debt |
$4,095,776 |
|
Total Liabilities |
$6,535,427 |
|
Total Stockholders' Equity |
$-1,406,745 |
| Total Liabilities and Equity |
$5,128,682 |
Statement of Comprehensive Income Information
|
Total Revenues |
$5,813,732 |
|
Costs & Expenses Applicable to Rev |
$4,674,643 |
|
Depreciation and Amortization |
$205,009 |
| Net Income |
$-641,722 |
|
Earnings Per Share - Basic |
$0.00 |
|
Earnings Per Share - Diluted |
$0.00 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
